CoChat

An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer

Open access
Ling, Shizhang, Chang, Xiaofei, Schultz, Luciana, Lee, Thomas K., Chaux, Alcides, Marchionni, Luigi, Netto, George J., Sidransky, David, Berman, David M. · 2011 · Cancer Research

Published version of a preprint

Cited by 121

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Like many carcinomas, urothelial carcinoma (UroCa) is associated with chronic injury. A better understanding of this association could inform improved strategies for preventing and treating this disease. We investigated the expression, regulation, and function of the transcriptional regulator SRY-related high-mobility group box 9 (Sox9) in urothelial development, injury repair, and cancer. In mouse bladders, Sox9 levels were high during periods of prenatal urothelial development and diminished with maturation after birth. In adult urothelial cells, Sox9 was quiescent but was rapidly induced by a variety of injuries, including exposure to the carcinogen cyclophosphamide, culture with hydrogen peroxide, and osmotic stress. Activation of extracellular signal–regulated kinases 1/2 (ERK1/2) was required for Sox9 induction in urothelial injury and resulted from activation of the epidermal growth factor receptor (Egfr) by several Egfr ligands that were dramatically induced by injury. In UroCa cell lines, SOX9 expression was constitutively upregulated and could be suppressed by EGFR or ERK1/2 blockade. Gene knockdown showed a role for SOX9 in cell migration and invasion. Accordingly, SOX9 protein levels were preferentially induced in invasive human UroCa tissue samples (n = 84) compared with noninvasive cancers (n = 56) or benign adjacent urothelium (n = 49). These results identify a novel, potentially oncogenic signaling axis linking urothelial injury to UroCa. Inhibiting this axis is feasible through a variety of pharmacologic approaches and may have clinical utility. Cancer Res; 71(11); 3812–21. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-3072

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 49

  1. Beachy, 2004, Mending and malignancy, Nature, 431, 402, 10.1038/431402a · DOI
  2. Kundu, 2008, Inflammation: gearing the journey to cancer, Mutat Res, 659, 15, 10.1016/j.mrrev.2008.03.002 · DOI · Paper page
  3. Michaud, 2007, Chronic inflammation and bladder cancer, Urol Oncol, 25, 260, 10.1016/j.urolonc.2006.10.002 · DOI · Paper page
  4. Martin, 2004, Parallels between tissue repair and embryo morphogenesis, J Embryol Exp Morphol, 131, 3021
  5. Ingber, 2007, What lies at the interface of regenerative medicine and developmental biology?, J Embryol Exp Morphol, 134, 2541
  6. Lefebvre, 2007, Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors, Int J Biochem Cell Biol, 39, 2195, 10.1016/j.biocel.2007.05.019 · DOI · Paper page
  7. Thomsen, 2008, The role of Sox9 in prostate development, Differentiation, 76, 728, 10.1111/j.1432-0436.2008.00293.x · DOI
  8. Wang, 2008, SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion, Cancer Res, 68, 1625, 10.1158/0008-5472.CAN-07-5915 · DOI · Paper page
  9. Schaeffer, 2008, Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer, Oncogene, 27, 7180, 10.1038/onc.2008.327 · DOI · Paper page
  10. Murakami, 2000, Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway, 1113
  11. Rossi, 2001, The immortalized UROtsa cell line as a potential cell culture model of human urothelium, Environ Health Perspect, 109, 801, 10.1289/ehp.01109801 · DOI · Paper page
  12. Summerhayes, 1979, Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro, J Natl Cancer Inst, 62, 1017
  13. Kleeberger, 2007, Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis, Cancer Res, 67, 9199, 10.1158/0008-5472.CAN-07-0806 · DOI · Paper page
  14. Klein, 1999, Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells, Bone Marrow Transplant, 24, 959, 10.1038/sj.bmt.1702009 · doi:10.1038/sj.bmt.1702009
  15. Berman, 2004, Roles for Hedgehog signaling in androgen production and prostate ductal morphogenesis, Dev Biol, 267, 387, 10.1016/j.ydbio.2003.11.018 · DOI
  16. Grishina, 2005, BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling, Dev Biol, 288, 334, 10.1016/j.ydbio.2005.08.018 · DOI
  17. Albini, 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells, Cancer Res, 47, 3239
  18. Cheung, 2009, Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence, J Urol, 181, 1387, 10.1016/j.juro.2008.10.146 · DOI
  19. Schultz, 2010, Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy, Cancer, 116, 5517, 10.1002/cncr.25502 · DOI
  20. Jezernik, 1993, Blood-urine barrier formation in mouse urinary bladder development, Anat Rec, 235, 533, 10.1002/ar.1092350405 · doi:10.1002/ar.1092350405
  21. Lewis, 2000, Everything you wanted to know about the bladder epithelium but were afraid to ask, Am J Physiol Renal Physiol, 278, F867, 10.1152/ajprenal.2000.278.6.F867 · DOI · Paper page
  22. Brandt, 2009, Urothelial carcinoma: stem cells on the edge, Cancer Metastasis Rev, 28, 291, 10.1007/s10555-009-9187-6 · DOI
  23. Farsund, 1976, Cell kinetics of mouse urinary bladder epithelium. II. Changes in proliferation and nuclear DNA content during necrosis regeneration, and hyperplasia caused by a single dose of cyclophosphamide, Virchows Arch B Cell Pathol, 21, 279, 10.1007/BF02899161 · doi:10.1007/bf02899161
  24. Anton, 2002, Delayed toxicity of cyclophosphamide on the bladder of DBA/2 and C57BL/6 female mouse, Int J Exp Pathol, 83, 47, 10.1046/j.1365-2613.2002.00208.x · doi:10.1046/j.1365-2613.2002.00208.x
  25. Wang, 2003, Importance of functional EGF receptors in recovery from acute nephrotoxic injury, J Am Soc Nephrol, 14, 3147, 10.1097/01.ASN.0000098681.56240.1A · DOI
  26. Eblin, 2007, Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis, Toxicol Sci, 95, 321, 10.1093/toxsci/kfl160 · doi:10.1093/toxsci/kfl160
  27. Messing, 1987, Epidermal growth factor–interactions with normal and malignant urothelium: in vivo and in situ studies, J Urol, 138, 1329, 10.1016/S0022-5347(17)43593-2 · doi:10.1016/s0022-5347(17)43593-2
  28. Chow, 1997, Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study, Virchows Arch, 430, 461, 10.1007/s004280050056 · doi:10.1007/s004280050056
  29. Sun, 2006, Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing, Am J Physiol Renal Physiol, 291, F9, 10.1152/ajprenal.00035.2006 · DOI
  30. Eblin, 2008, Immortalized human urothelial cells as a model of arsenic-induced bladder cancer, Toxicology, 248, 67, 10.1016/j.tox.2008.03.020 · DOI
  31. Freeman, 1997, Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder, J Clin Invest, 99, 1028, 10.1172/JCI119230 · DOI · Paper page
  32. Lezama, 2005, Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions, Neurochem Res, 30, 1589, 10.1007/s11064-005-8837-5 · DOI
  33. Goldkorn, 1998, EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress, Am J Respir Cell Mol Biol, 19, 786, 10.1165/ajrcmb.19.5.3249 · DOI · Paper page
  34. Yin, 2007, Wound-induced ATP release and EGF receptor activation in epithelial cells, J Cell Sci, 120, 815, 10.1242/jcs.03389 · DOI · Paper page
  35. Wu, 2005, Urothelial tumorigenesis: a tale of divergent pathways, Nat Rev Cancer, 5, 713, 10.1038/nrc1697 · DOI · Paper page
  36. Wang, 2009, Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9, Cell Metab, 9, 287, 10.1016/j.cmet.2009.01.013 · DOI · Paper page
  37. de Crombrugghe, 2000, Transcriptional mechanisms of chondrocyte differentiation, Matrix Biol, 9, 389, 10.1016/S0945-053X(00)00094-9 · DOI · Paper page
  38. Moniot, 2004, SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals, J Embryol Exp Morphol, 131, 3795
  39. Okubo, 2005, Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation, J Embryol Exp Morphol, 132, 1363
  40. Lavelle, 2002, Bladder permeability barrier: recovery from selective injury of surface epithelial cells, Am J Physiol Renal Physiol, 283, F242, 10.1152/ajprenal.00307.2001 · DOI · Paper page
  41. Messing, 1990, Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma, Cancer Res, 50, 2530
  42. Baskin, 1997, Growth factors in bladder wound healing, J Urol, 157, 2388, 10.1016/S0022-5347(01)64786-4 · DOI
  43. Mysorekar, 2002, Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli, J Biol Chem, 277, 7412, 10.1074/jbc.M110560200 · DOI · Paper page
  44. He, 2009, Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma, Stem Cells, 27, 1487, 10.1002/stem.92 · DOI
  45. Beachy, 2004, Tissue repair and stem cell renewal in carcinogenesis, Nature, 432, 324, 10.1038/nature03100 · DOI · Paper page
  46. Burin, 1995, Human bladder cancer: evidence for a potential irritation-induced mechanism, Food Chem Toxicol, 33, 785, 10.1016/0278-6915(95)00045-4 · DOI
  47. Gelfand, 1967, Relation between carcinoma of the bladder and infestation with Schistosoma haematobium, Lancet, 1, 1249, 10.1016/S0140-6736(67)92714-6 · DOI
  48. Smith, 1998, Marked increase in bladder and lung cancer mortality in a region of northern chile due to arsenic in drinking water, Am J Epidemiol, 147, 660, 10.1093/oxfordjournals.aje.a009507 · DOI · Paper page
  49. Sens, 2004, Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells, Toxicol Sci, 79, 56, 10.1093/toxsci/kfh086 · DOI

Cited by

See all 121

Metadata

Authors
Ling, S., Chang, X., Schultz, L., Lee, T. K., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M.
Venue
Cancer Research
Published
2011-05-31
Volume
71
Issue
11
Pages
3812-3821
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2018143149
Cited by
121
References
1
FWCI
9.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-3072
The paper
Ling, S., Chang, X., Schultz, L., Lee, T. K., Chaux, A., Marchionni, L., Netto, G. J., Sidransky, D., & Berman, D. M. (2011). An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-3072

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.